Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MKNK1 | Q9BUB5 | 5/20 | 0.52 |
| ▸ | MKNK2 | Q9HBH9 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.52 |
| ▸ | AXL | P30530 | 1/20 | 0.52 |
| ▸ | ERN1 | O75460 | 2/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12129629 | 0.90 | CYP11B1 (0.64) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL31508264 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL12956908 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL12068478 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL12108682 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL9008997 | 0.87 | CYP3A4 (0.54) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL1026845 | 0.85 | CYP11B1 (0.68) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL21296912 | 0.85 | CYP2A6 (0.62) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL29567050 | 0.85 | CYP11B1 (0.68) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 | |
| SCHEMBL30295066 | 0.85 | CYP11B1 (0.68) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793683-B2 | Block co-poly(metal organic nanostructures) (BCPMONs) and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-10-06 | — | — | US | disclosed |
| US-20180258233-A9 | BLOCK CO-POLY(METAL ORGANIC NANOSTRUCTURES) (BCPMONS) AND USES THEREOF | NATIONAL SCIENCE FOUNDATION | 2018-09-13 | — | — | US | disclosed |
| WO-2018022944-A1 | BLOCK CO-POLY(METAL ORGANIC NANOSTRUCTURES) (BCPMONs) AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-02-01 | — | — | WO | disclosed |
| US-20180030213-A1 | BLOCK CO-POLY(METAL ORGANIC NANOSTRUCTURES) (BCPMONS) AND USES THEREOF | MASSACHUSETTS INST TECHNOLOGY (US) | 2018-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030213-A1 | BLOCK CO-POLY(METAL ORGANIC NANOSTRUCTURES) (BCPMONS) AND USES THEREOF | MB, EBPL, POF1B | CYP2A6 4073/4885ALDH1A1 2224/4885CYP3A4 3081/4885 |
| US-10793683-B2 | Block co-poly(metal organic nanostructures) (BCPMONs) and uses thereof | MB, EBPL, POF1B | CYP2A6 4073/4885ALDH1A1 2224/4885CYP3A4 3081/4885 |
| US-20180258233-A9 | BLOCK CO-POLY(METAL ORGANIC NANOSTRUCTURES) (BCPMONS) AND USES THEREOF | MB, EBPL, POF1B | CYP2A6 4073/4885ALDH1A1 2224/4885CYP3A4 3081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.